200,000+ products from a single source!
sales@angenechem.com
CAS No: 245116-90-9 Catalog No: AG002ODX MDL No:MFCD08067733
Title | Journal |
---|---|
Identification of new non-carboxylic acid containing inhibitors of aldose reductase. | Bioorganic & medicinal chemistry 20100601 |
Diabetic cataract-pathogenesis, epidemiology and treatment. | Journal of ophthalmology 20100101 |
Discovery of [3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrrolo[2,3-b]pyridin-1-yl]acetic acids as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications. | Bioorganic & medicinal chemistry letters 20090401 |
Regulation of plasma fructose and mortality in mice by the aldose reductase inhibitor lidorestat. | The Journal of pharmacology and experimental therapeutics 20090201 |
Synthesis, induced-fit docking investigations, and in vitro aldose reductase inhibitory activity of non-carboxylic acid containing 2,4-thiazolidinedione derivatives. | Bioorganic & medicinal chemistry 20080601 |
Discovery of 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications. | Journal of medicinal chemistry 20050505 |
Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. | Endocrine reviews 20050501 |
© 2019 Angene International Limited. All rights Reserved.